Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Merck
Harvard Business School
Mallinckrodt
US Army
Cipla
AstraZeneca
Deloitte
Chinese Patent Office

Generated: February 25, 2018

DrugPatentWatch Database Preview

Bumetanide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for bumetanide and what is the scope of bumetanide patent protection?

Bumetanide
is the generic ingredient in two branded drugs marketed by Athenex Inc, Hospira, Teva Parenteral, West-ward Pharms Int, Validus Pharms, Amneal Pharms Co, Ivax Sub Teva Pharms, Sandoz, and Upsher-smith Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for bumetanide. Twenty suppliers are listed for this compound.
Pharmacology for bumetanide
Medical Subject Heading (MeSH) Categories for bumetanide

US Patents and Regulatory Information for bumetanide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms BUMETANIDE bumetanide TABLET;ORAL 074225-002 Apr 24, 1995 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms Co BUMETANIDE bumetanide TABLET;ORAL 209724-002 Oct 18, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Upsher-smith Labs BUMETANIDE bumetanide TABLET;ORAL 209916-003 Jan 23, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Upsher-smith Labs BUMETANIDE bumetanide TABLET;ORAL 209916-001 Jan 23, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms BUMETANIDE bumetanide TABLET;ORAL 074225-003 Apr 24, 1995 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz BUMETANIDE bumetanide TABLET;ORAL 074700-001 Nov 21, 1996 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Validus Pharms BUMEX bumetanide INJECTABLE;INJECTION 018226-001 Feb 28, 1983 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira BUMETANIDE bumetanide INJECTABLE;INJECTION 074332-001 Oct 31, 1994 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Parenteral BUMETANIDE bumetanide INJECTABLE;INJECTION 074613-001 Nov 18, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms Co BUMETANIDE bumetanide TABLET;ORAL 209724-003 Oct 18, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for bumetanide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms BUMEX bumetanide INJECTABLE;INJECTION 018226-001 Feb 28, 1983 ➤ Sign Up ➤ Sign Up
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-002 Feb 28, 1983 ➤ Sign Up ➤ Sign Up
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-003 Jun 14, 1985 ➤ Sign Up ➤ Sign Up
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-001 Feb 28, 1983 ➤ Sign Up ➤ Sign Up
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-003 Jun 14, 1985 ➤ Sign Up ➤ Sign Up
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-003 Jun 14, 1985 ➤ Sign Up ➤ Sign Up
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-001 Feb 28, 1983 ➤ Sign Up ➤ Sign Up
Validus Pharms BUMEX bumetanide INJECTABLE;INJECTION 018226-001 Feb 28, 1983 ➤ Sign Up ➤ Sign Up
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-002 Feb 28, 1983 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Farmers Insurance
Chinese Patent Office
McKinsey
Harvard Business School
Cipla
Citi
Federal Trade Commission
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot